With more than 100,000 survivors and activists, we are the world's largest, most progressive
grassroots network of people fighting to end breast cancer forever. As the face and voice of the global breast cancer movement...
We are local activists in more than 120 cities and communities, mobilizing more than 1.7 million friends and neighbors each year through events like the Susan G. Komen Race for the Cure® Series.
We are advocates at the local, state and federal level, fighting for the screening and treatment
programs that save lives and the research that brings us closer to the cures.
We are global citizens working with local health groups around the world and through komen.org to help millions of women in nearly 200 countries overcome the social, cultural and economic barriers to breast health and treatment.
Prior to assuming the role of Interim President & CEO, Ellen Willmott served as General Counsel and Corporate Secretary, responsible for the overall legal and risk management affairs of Susan G. Komen®, including oversight of the Internal Audit and Legal Departments, as well as supporting the Board of Directors and Komen by providing legal advice and risk management counseling to the Board and executive staff of the organization. Learn more about Ellen now.
Connie O’Neill has been involved with Susan G. Komen since 1992. She served as treasurer of the organization for two years and chaired the National Awards Luncheon in 1994. In 2000, she was again appointed Komen Board treasurer and has continued to serve in that role. In June 2016, O’Neill assumed the role of Chair of the Komen Board of Directors.Learn more about Connie now.
As chief financial officer for Susan G. Komen®, Bob Green is responsible for all financial matters affecting the world's largest breast cancer organization, including the oversight of Komen's financial, accounting, information technology and human resources systems. Green will guide financial strategy for operations at Komen's headquarters as well as its global network of Affiliates.Learn
more about Bob now.
As senior vice president, development for Susan G. Komen®, Christina Alford is responsible for leading Komen's Development, Major Gifts, CRM, Direct Marketing and Donor Services teams.Learn more about Christina now.
Prior to assuming the role of Deputy General Counsel and Assistant Corporate Secretary, Lesley Lurie served as Vice President, Assistant General Counsel and Assistant Corporate Secretary for Susan G. Komen. She oversees various responsibilities of the legal department, helps coordinate the development and implementation of legal processes and policies for Komen and provides counsel to all departments within the organization.Learn more about Lesley now.
As senior vice president, affiliate network for Susan G. Komen®, Lori Maris provides guidance and direction to the Komen global headquarters team and local Affiliate leadership in matters related to governance, financial compliance/reporting, organizational development and structure, event planning and operations, mission delivery, fundraising and day-to-day Affiliate operations.Learn more about Lori now.
As vice president, information technology for Susan G. Komen®, Eric Montgomery is responsible for the IT function of the world's largest breast cancer organization. In this role, Montgomery oversees enterprise IT solutions for Komen's global infrastructure and operational needs.Learn more about Eric now.
As vice president, human resources for Susan G. Komen®, Catherine Olivieri oversees the people-related programs and policies to connect and align business to people strategies throughout the organization. This includes talent acquisition, talent management, employee
benefits, compensation, employee relations, succession planning and organizational development. She assures that Susan G. Komen complies with requirements of ERISA, EEO and all federal, state and local statutes in support of the world's largest breast cancer organization.Learn more about Catherine now.
As corporate controller for Susan G. Komen®, Ria Williams is responsible for the strategy and direction of the financial reporting and analysis functions for Headquarters and its global network of Affiliates. She assists the CFO with strategic and tactical matters as they relate to budget management, forecasting needs and strategic decision-making to help the organization achieve its mission of ending breast cancer forever.Learn more about Ria now.
As vice president, research and community health program operations for Susan G. Komen®, Victoria Wolodzko is responsible for Komen’s research, national community health and global grants, programs, and strategic partnerships, along with grant-making operations for the Affiliate Network. In this role, Wolodzko works closely with Komen’s mission advisors, including the Scientific Advisory Board, Komen Scholars, and Advocates in Science Steering Committee.Learn more about Victoria now.
Our Board of Directors governs and advises us in our endeavors to save lives and end breast cancer forever, and leads our efforts to fund the best science and equip the boldest communities in order to
make the biggest impact.
Jane Abraham was elected to Komen's Board of Directors on May 31, 2012, after serving as an interim board member and as a member of the Komen Advocacy Alliance Board of Directors. The wife of former Senator and U.S. Secretary of Energy Spencer Abraham, she has long been a breast cancer advocate, having actively participated for a number of years in both the annual Susan G. Komen Washington D.C. Race for the Cure (formerly known as the Global Race for the Cure) and Race for the Cure events in her home state of Michigan. She serves on the boards of the Detroit-based Covenant House Michigan, the Arab American National Museum, and The Nurturing Network and is general chairman of the Susan B. Anthony List. Abraham is president of Abraham Strategies LLC., which handles strategic marketing assignments for a variety of clients.
Kaye Ceille joined the Komen Board in 2015. She is president of Zipcar, the world’s largest car sharing service. Ceille brings nearly two decades of experience in senior leadership positions in the travel and transportation industry, including international operations, global partnerships and business development with Zipcar’s parent, the Avis Budget Group. Ceille received a Bachelor of Business Administration degree from St. Norbert College in De Pere, Wisconsin, and an MBA from Loyola University in Chicago. Ceille is a cancer survivor who is active in cancer organizations.
Linda Custard, is a full-time volunteer with a wide range of experience in educational, cultural and social service boards. She has served as president of the Junior League of Dallas, vice chair of the United Way of Metropolitan Dallas, chair of the Board of Trustees of the Hockaday School, president of the Community Council of Greater Dallas and president of the Dallas Woman's Club. Presently, she serves as a trustee of Southern Methodist University and as a director of the Dallas Center for the Performing Arts Foundation. She has served on the Susan G. Komen board since 1982.
Alan D. Feld joined Akin Gump Strauss, Hauer and Feld, LLP in 1960 and is one of three senior executive partners in one of the world’s most respected law firms. He was appointed by the governor to the Texas State Securities Board in 1985 and served as the board’s chairman through 1991. In 1998 he was honored by the Southern Methodist University Dedman School of Law with the establishment of the Alan D. Feld Professorship. He currently serves as chairman of the Southern Methodist University Dedman School of Law’s executive board. He has served on the American Bar Association Commission on Opportunities for Minorities in its Profession. He was a member of the board of directors of the Dallas Citizen Council, a trustee of Southern Methodist University, board of visitors member for UT Southwestern University Hospitals and Clinics, board of visitors member at the University of Texas M.D. Anderson Cancer Center, and a former board member of the ARC, Timberlawn Psychiatric Research Foundation, Dallas Symphony Orchestra and Brandeis University.
Janet Dunn Frantz, a 15-year breast cancer survivor, joined the Komen Board in 2015 as one of two board members nominated by Komen’s Affiliate Network. Frantz previously served as Board President and Board Secretary of the Komen Virginia Blue Ridge Affiliate. She is an avid Komen supporter, participating in 3-Day walks and leading a top fundraising team in the Virginia Blue Ridge Komen Race for the Cure. Frantz has a background in commercial banking and spent her entire career with Bank of America and predecessor banks. Janet received a Bachelor of Arts in Economics from Wake Forest University.
Dan Glennon joined the Board in 2015. He is Chief Operating Officer and Chief Financial Officer at SPANX. Prior to joining SPANX, Glennon held a number of strategic financial roles, including serving as Executive Vice President and Chief Financial Officer of Teavana, and most recently as the Chief Financial Officer of Larson-Juhl, a Berkshire-Hathaway subsidiary. Glennon earned his Bachelor of Business Administration degree from the University of Georgia and his MBA from Harvard.
Melissa Maxfield, Senior Vice President, Federal Government Affairs, for Comcast NBCUniversal, joined the Komen Board in 2015. In her role with Comcast NBCUniversal, she was honored as one of MultiChannel News’ Wonder Women for 2015 and named among the Most Powerful Women in Cable in 2012, 2013 and 2014 by CableFAX: The Magazine. Prior to joining Comcast in 2003, Maxfield served as the top staffer for Senate Majority Leader Tom Daschle (SD) and Senator Bob Kerrey (NE). She received her Bachelor’s Degree in Political Science from Randolph-Macon Woman’s College in Lynchburg, VA.
Dr. Olufunmilayo “Funmi” Olopade, M.D., F.A.C.P. currently serves as one of the Komen Scholars, an advisory group of 70 distinguished scholars and leaders in breast cancer research who participate in Komen's scientific peer review process. As a widely respected leader in breast cancer research, Dr. Olopade’s work has helped scientists around the globe gain a greater understanding of breast cancer. A highly skilled hematology oncologist with proven expertise in cancer risk assessment, Dr. Olopade is an expert on individualized treatment for breast cancer as well as quality of life concerns for breast cancer patients. She currently serves as Director of the Center for Clinical Cancer Genetics and Professor of Medicine and Human Genetics at the University of Chicago.
Meghan Shannon, shareholder in the business law practice at Reinhart Boerner Van Deuren s.c. in Milwaukee, Wisconsin. She joined the Komen board in 2015. For the past six years, Shannon has been actively involved with the Komen Southeastern Wisconsin Affiliate, where she served as Board President and Treasurer. Shannon also was nominated through Komen’s Affiliate Network and brings experience in many areas of corporate, business and finance law. She received her undergraduate degree in Accounting from the University of Notre Dame and her law degree from the University of Wisconsin law school. She is a certified public accountant.
Trish Wheaton joined the Komen Board in 2016. Based in New York City, she holds dual roles in the global advertising agency Young & Rubicam where she is Global Managing Partner and President/Founder of INSPIRE, a multi-disciplinary practice focused on sustainability marketing. Previously Wheaton served as CMO of Wunderman, a global digital agency, and headed Wunderman offices in Canada and the U.K. In 2013 she was inducted into the Marketing Hall of Femme, joining an elite group of women leading marketing today. After graduating from Gustavus Adolphus College, Wheaton was a U.S. Peace Corps Volunteer to Kenya. She holds a master’s degree from the University of Minnesota.
Linda Wilkins has been a longtime supporter of Susan G. Komen, serving six years on the Komen Dallas Affiliate board. As a breast cancer advocate and survivor, Wilkins brings to Komen her passion for the cause. She is a tax attorney and founding partner of her certified women-owned law firm Wilkins Finston Friedman Law Group LLP in Dallas. She has practiced in the areas of ERISA, employee benefits, compensation and tax law for over 30 years.
Angela Zepeda joined the Komen Board in 2016. She is SVP, Business Development at INNOCEAN USA, a global advertising agency working with clients such as Hyundai, KIA, Genesis, Taylor Made, Champion, Finish Line and many others. Angela is responsible for leading and managing all marketing and growth initiatives for the agency’s U.S. footprint. Prior to INNOCEAN, Angela spent over a decade at Campbell-Ewald Los Angeles in addition to holding positions at some of LA’s most respected agencies, including TBWA/Chiat Day, Team One, Rapp Collins, Doner, and FCB. She has a wide background in several industrial sectors including automotive, healthcare, education, financial services, and packaged goods, in addition to expertise in marketing to women. Angela holds an MBA from the University of Southern California and a Bachelor of Arts degree in Communications/Advertising from California State University, Fullerton.
Nancy G. Brinker is regarded as the leader of the global breast cancer movement. Her journey began with a simple promise to her dying sister, Susan G. Komen, that she would do everything possible to end the shame, pain, fear and hopelessness caused by this disease. In one generation, the organization that bears Susan's name has changed the world. Learn more about Nancy now.
Our mission advisors are rock stars—the best and brightest researchers, clinicians, advocates and other experts who help guide and implement our mission programs. Thanks to their efforts, we’re driving discovery, affecting change and accelerating progress in the fight against breast cancer.
The Scientific Advisory Board (SAB) provides strategic guidance and direction for our research and scientific programs. It helps prioritize our global research investment and serves as the executive committee of the Komen Scholars. Learn more about the esteemed members now.
The Komen Scholars are an advisory group of 60 distinguished leaders in breast cancer research and advocacy. Representing more than 32 institutions in seven countries, their expertise spans everything from clinical research, laboratory research, pathology, prevention, radiation oncology, surgery and other disciplines and specialties. They contribute to our programs, activities and events in many ways, most notably our scientific peer review process, and act as our ambassadors in communities around the U.S. and the world. Get to know our Komen Scholars now.
The Advocates in Science Steering Committee is comprised of seven advocates who’ve demonstrated their dedication and leadership in breast cancer advocacy. The committee works closely with Komen staff, both locally and nationally, to develop the strategy for the AIS program, expand its community of members and leverage the benefits of effective breast cancer research advocacy. They are also active members of either the Komen Scholars or the Scientific Advisory Board. Get to know the members of our AIS steering committee now.
Thanks to survivors, volunteers and activists dedicated to the fight against breast cancer, the Komen Affiliate Network is the nation's largest private funder of community-based breast health education and breast cancer screening/treatment site.
To make a request for a representative from Susan G. Komen to attend or speak at a third-party event, please fill out this form. Please complete every field on the form with as much detail as possible.
Komen leadership attendance at events is subject to availability, and we are unable to guarantee fulfillment of every request. After submitting the form, you will be notified when your request has been processed and whether a Komen representative will be able to attend.
Careers & Opportunities